
MANNKIND CORP
MANNKIND CORP (MNKD)
WebsitePrice
Market cap
Next catalystINHALE-1ST pilot findings at ISPAD in November 2026Afrezza plus basal insulin — INHALE-1ST · Data readoutCompany source ↗
Cash
Chart & Events
Core Clinical
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
Other pipelines
PreINDP1P2P3FilingApproved
Partner / License out
Approved / commercial
History / paused
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved